Skip to main content

Infectious Agents and Cancer

Ausgabe 1/2024

Inhalt (25 Artikel)

Open Access Research

The prognostic role of PD-L1 expression and the presence of polyomavirus in Merkel cell carcinoma cases

Stella Meireles Siqueira, Gabriella Campos-do-Carmo, Paulo Ricardo Garcia da Silva, Isabele Ávila Small, Andreia Cristina De Melo

Open Access Review

A systematic review of endometrial cancer clinical research in Africa

Chidinma P. Anakwenze, Agnes Ewongwo, Louisa Onyewadume, Ademola Oyekan, Chinelo Onwualu Chigbo, Luca Valle, Yimin Geng, Paul Olapade, Kenechukwu Okwunze, Nwamaka Lasebikan, Anuja Jhingran, Onyinye D. Balogun, Atara Ntekim

Open Access Research

Trends in gynaecologic cancer mortality and the impact of the COVID-19 pandemic in the United States

Yuyan Xi, Yuxin Guo, Sikai Qiu, Fan Lv, Yujiao Deng, Jingyi Xie, Zixuan Xing, Yajing Bo, Chenyu Chang, Fan Zhang, Fanpu Ji, Mu Li

Open Access Research

The global burden of cervical cancer requiring surgery: database estimates

Emma R Allanson, Syed Nabeel Zafar, Chidinma P Anakwenze, Kathleen M Schmeler, Edward L Trimble, Surbhi Grover

Open Access Research

Nelfinavir inhibition of Kaposi’s sarcoma-associated herpesvirus protein expression and capsid assembly

Maggie Li, Barbara J. Smith, Jaeyeun Lee, Jennifer Petr, Nicole M. Anders, Robyn Wiseman, Michelle A. Rudek, Richard F. Ambinder, Prashant J. Desai

Open Access Research

Impact of plasma Epstein–Barr virus DNA in posttreatment nasopharyngeal carcinoma patients after SARS-CoV-2 infection

Cheng Lin, Meifang Li, Yingying Lin, Yu Zhang, Hanchuan Xu, Bijuan Chen, Xia Yan, Yun Xu

Open Access Correspondence

No detectable truncating mutations in large T antigen (LT-Ag) sequence of Merkel cell polyomavirus (MCPyV) DNA obtained from porocarcinomas

Rosaria Arvia, Mauro Sollai, Daniela Massi, Patricia Asensio-Calavia, Carmelo Urso, Krystyna Zakrzewska

Open Access Research

A prognostic model for Schistosoma japonicum infection-associated liver hepatocellular carcinoma: strengthening the connection through initial biological experiments

Shuyan Sheng, Bangjie Chen, Ruiyao Xu, Yanxun Han, Deshen Mao, Yuerong Chen, Conghan Li, Wenzhuo Su, Xinyang Hu, Qing Zhao, Scott Lowe, Yuting Huang, Wei Shao, Yong Yao

Open Access Review

Cervicovaginal microbiota: a promising direction for prevention and treatment in cervical cancer

Jie Shen, Hao Sun, Jing Chu, Xiaodi Gong, Xiaojun Liu

Open Access Review

Undifferentiated carcinoma of the liver with osteoclast-like giant cells: a case report and literature review

Lixia Lu, Li Wang, Can Peng, Li Chen, Ximan He, Chenning Shao, Chunnian Wang, Rong Ge

Open Access Research

Shared genetic factors and causal association between chronic hepatitis C infection and diffuse large B cell lymphoma

Leihua Fu, Jieni Yu, Zhe Chen, Feidan Gao, Zhijian Zhang, Jiaping Fu, Weiying Feng, Pan Hong, Jing Jin

Open Access Research

Hepatitis B virus reactivation in hepatocellular carcinoma patients after hepatic arterial infusion chemotherapy combined with and without immunotherapy

Lijie Zhang, Yiming Liu, Songlin Song, Joyman Makamure, Heshui Shi, Chuansheng Zheng, Bin Liang

Open Access Research

Expression of 10 circulating cytokines/chemokines in HBV-related liver disease

Yanfang Jia, Xiaolei Jiao, Wenxia Shi, Ying Luo, Huiling Xiang, Jing Liang, Yingtang Gao

Open Access Research

Prevalence of metabolic syndrome among patients with hepatocellular carcinoma of different etiologies: a retrospective study

Da-Long Yang, Shao-Ping Liu, Hong-Liang Wang, Jian-Rong Li, Jia-Yong Su, Min-Jun Li, Yu-Xian Teng, Zhu-Jian Deng, Zhong-Hai Li, Jian-Li Huang, Ping-Ping Guo, Liang Ma, Zhen-Zhen Li, Jian-Hong Zhong

Open Access Research

The performance of single and combination test strategies using visual inspection, cytology, high-risk HPV DNA and HPV16/18 to screen South African women with and without HIV-infection

Greta Dreyer, Cathy Visser, Gerrit Jan Dreyer, Matthys H. Botha, Frederick H. van der Merwe, Karin L. Richter, Leon C. Snyman

Open Access Research

Human T-cell lymphotropic virus type 1 (HTLV-1) grip on T-cells: investigating the viral tapestry of activation

Arash Letafati, Atefeh Bahavar, Alijan Tabarraei, Mehdi Norouzi, Abdollah Amiri, Sayed-Hamidreza Mozhgani

Open Access Research

Comparison of the ScreenFire and Xpert HPV assays for the detection of human papillomavirus and cervical precancer among women living with HIV in Malawi

Chemtai Mungo, Anagha Guliam, Lameck Chinula, Federica Inturrisi, Lizzie Msowoya, Tawonga Mkochi, Siniya Jawadu, Silvia de Sanjosé, Mark Schiffman, Jennifer H. Tang, Jennifer S. Smith

Open Access Research

The patients with multiple myeloma were infected with COVID-19 during autologous stem cell transplantation: case report and literature review

Chang Su, Lijun Huang, Liang Liang, Lijia Ou, Guige Lu, Caiqin Wang, Yizi He, Ruolan Zeng, Yajun Li, Hui Zhou, Ling Xiao

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.